Screener
IDEAYA Biosciences, Inc. IDYA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 300,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 87,856,154 and 87,796,561 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | 9 | 9 |
| Additional paid-in capital | 1,772,830 | 1,757,197 |
| Accumulated other comprehensive (loss) income | (494) | 2,267 |
| Accumulated deficit | (835,078) | (736,539) |
| Total stockholders’ equity | 937,267 | 1,022,934 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s common stock?
- IDEAYA Biosciences, Inc. (IDYA) reported common stock of $9K in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s common stock changed year-over-year?
- IDEAYA Biosciences, Inc.'s common stock decreased by 0.0% year-over-year, from $9K to $9K.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s common stock?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s common stock has grown at a 24.6% compound annual growth rate (CAGR), from $3K to $9K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about IDEAYA Biosciences, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude